Annual Cash & Cash Equivalents
$17.51 M
+$4.07 M+30.31%
December 31, 2023
Summary
- As of February 12, 2025, IMMX annual cash & cash equivalents is $17.51 million, with the most recent change of +$4.07 million (+30.31%) on December 31, 2023.
- During the last 3 years, IMMX annual cash & cash equivalents has risen by +$17.12 million (+4377.06%).
- IMMX annual cash & cash equivalents is now -0.76% below its all-time high of $17.64 million, reached on December 31, 2021.
Performance
IMMX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$19.69 M
-$4.28 M-17.87%
September 30, 2024
Summary
- As of February 12, 2025, IMMX quarterly cash and cash equivalents is $19.69 million, with the most recent change of -$4.28 million (-17.87%) on September 30, 2024.
- Over the past year, IMMX quarterly cash and cash equivalents has increased by +$108.00 thousand (+0.55%).
- IMMX quarterly cash and cash equivalents is now -32.84% below its all-time high of $29.32 million, reached on March 31, 2024.
Performance
IMMX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
IMMX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.3% | +0.6% |
| 3 y3 years | +4377.1% | +0.6% |
| 5 y5 years | +2285.5% | +0.6% |
IMMX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.8% | +30.3% | -32.8% | +71.8% |
| 5 y | 5-year | -0.8% | +4377.1% | -32.8% | >+9999.0% |
| alltime | all time | -0.8% | +4377.1% | -32.8% | >+9999.0% |
Immix Biopharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $19.69 M(-17.9%) |
| Jun 2024 | - | $23.98 M(-18.2%) |
| Mar 2024 | - | $29.32 M(+67.4%) |
| Dec 2023 | $17.51 M(+30.3%) | $17.51 M(-10.6%) |
| Sep 2023 | - | $19.58 M(+54.8%) |
| Jun 2023 | - | $12.65 M(+10.4%) |
| Mar 2023 | - | $11.46 M(-14.7%) |
| Dec 2022 | $13.44 M | $13.44 M(-20.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $16.92 M(-8.1%) |
| Jun 2022 | - | $18.40 M(-3.5%) |
| Mar 2022 | - | $19.06 M(+8.0%) |
| Dec 2021 | $17.64 M(+4411.5%) | $17.64 M(>+9900.0%) |
| Sep 2021 | - | $38.00 K(-65.6%) |
| Jun 2021 | - | $110.60 K(-71.7%) |
| Dec 2020 | $391.10 K(-46.7%) | $391.10 K |
| Dec 2019 | $734.00 K | - |
FAQ
- What is Immix Biopharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Immix Biopharma?
- What is Immix Biopharma annual cash & cash equivalents year-on-year change?
- What is Immix Biopharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Immix Biopharma?
- What is Immix Biopharma quarterly cash and cash equivalents year-on-year change?
What is Immix Biopharma annual cash & cash equivalents?
The current annual cash & cash equivalents of IMMX is $17.51 M
What is the all time high annual cash & cash equivalents for Immix Biopharma?
Immix Biopharma all-time high annual cash & cash equivalents is $17.64 M
What is Immix Biopharma annual cash & cash equivalents year-on-year change?
Over the past year, IMMX annual cash & cash equivalents has changed by +$4.07 M (+30.31%)
What is Immix Biopharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of IMMX is $19.69 M
What is the all time high quarterly cash and cash equivalents for Immix Biopharma?
Immix Biopharma all-time high quarterly cash and cash equivalents is $29.32 M
What is Immix Biopharma quarterly cash and cash equivalents year-on-year change?
Over the past year, IMMX quarterly cash and cash equivalents has changed by +$108.00 K (+0.55%)